However, as with leptin, evidence linking adiponectin to recurrence or survival is mixed [4,5,6,7], and adiponectin and its receptors have been detected in breast cancer tissue indicating that autocrine as well as paracrine and endocrine pathways are operative [27]. Here, ADIPOQ is linked to breast cancer.